Jamie Terran1, Brian J McHugh2, Charla R Fischer1, Baron Lonner1, Daniel Warren3, Steven Glassman4, Keith Bridwell5, Frank Schwab1, Virginie Lafage1. 1. Department of Orthopaedic Surgery, New York University Hospital for Joint Diseases, New York, NY. 2. Department of Neurosurgery, Yale University School of Medicine, New Haven, CT. 3. Department of Neurosurgery, Vancouver Island Health Authority, Vancouver, British Columbia, CAN. 4. Department of Orthopaedic Surgery, University of Louisville, Louisville, KY. 5. Department of Orthopedic Surgery, Washington University in St. Louis, St. Louis, MO.
Abstract
BACKGROUND: In the United States, expenditures related to spine care are estimated to account for $86 billion annually. Policy makers have set a cost-effectiveness benchmark of less than $100,000/quality adjusted life year (QALY), forcing surgeons to defend their choices economically. This study projects the cost/QALY for surgical treatment of adult spinal deformity at 5-year follow-up based on 2-year cost- and health-related quality-of-life (HRQOL) data. METHODS: In a review of 541 patients with adult spinal deformity, the patients who underwent revision or were likely to undergo revision were identified and cost of surgery was doubled to account for the second procedure; all other patients maintained the cost of the initial surgery. Oswestry Disability Index (ODI) was modeled by revision status based on literature findings. Total surgical cost was based on Medicare reimbursement. Chi square and student t tests were utilized to compare cost-effective and non-cost-effective patients. RESULTS: The average cost/QALY at 5-year follow-up was $120,311.73. A total of 40.7% of patients fell under the threshold of a cost/QALY <$100,000. Cost-effective patients had higher baseline ODI scores (45% vs 34% [P=0.001]), lower baseline total Scoliosis Research Society scores (2.89 vs 3.00 [P=0.04]), and shorter fusions (8.23 vs 9.87 [P=0.0001]). CONCLUSION: We found 40.7% of patients to be below the threshold of cost effectiveness. Factors associated with reaching the threshold <$100,000/QALY were greater preoperative disability, diagnosis of idiopathic scoliosis, poor preoperative HRQOL scores, and fewer fusion levels.
BACKGROUND: In the United States, expenditures related to spine care are estimated to account for $86 billion annually. Policy makers have set a cost-effectiveness benchmark of less than $100,000/quality adjusted life year (QALY), forcing surgeons to defend their choices economically. This study projects the cost/QALY for surgical treatment of adult spinal deformity at 5-year follow-up based on 2-year cost- and health-related quality-of-life (HRQOL) data. METHODS: In a review of 541 patients with adult spinal deformity, the patients who underwent revision or were likely to undergo revision were identified and cost of surgery was doubled to account for the second procedure; all other patients maintained the cost of the initial surgery. Oswestry Disability Index (ODI) was modeled by revision status based on literature findings. Total surgical cost was based on Medicare reimbursement. Chi square and student t tests were utilized to compare cost-effective and non-cost-effective patients. RESULTS: The average cost/QALY at 5-year follow-up was $120,311.73. A total of 40.7% of patients fell under the threshold of a cost/QALY <$100,000. Cost-effective patients had higher baseline ODI scores (45% vs 34% [P=0.001]), lower baseline total Scoliosis Research Society scores (2.89 vs 3.00 [P=0.04]), and shorter fusions (8.23 vs 9.87 [P=0.0001]). CONCLUSION: We found 40.7% of patients to be below the threshold of cost effectiveness. Factors associated with reaching the threshold <$100,000/QALY were greater preoperative disability, diagnosis of idiopathic scoliosis, poor preoperative HRQOL scores, and fewer fusion levels.
Entities:
Keywords:
Cost-benefit analysis; quality adjusted life years; quality of life; scoliosis; spine; surgical procedures–operative
Authors: Gordon L Kindlmann; David M Weinstein; Greg M Jones; Christopher R Johnson; Mario R Capecchi; Charles Keller Journal: Mol Imaging Date: 2005 Oct-Dec Impact factor: 4.488
Authors: Anna N A Tosteson; Jon D Lurie; Tor D Tosteson; Jonathan S Skinner; Harry Herkowitz; Todd Albert; Scott D Boden; Keith Bridwell; Michael Longley; Gunnar B Andersson; Emily A Blood; Margaret R Grove; James N Weinstein Journal: Ann Intern Med Date: 2008-12-16 Impact factor: 25.391
Authors: Brook I Martin; Richard A Deyo; Sohail K Mirza; Judith A Turner; Bryan A Comstock; William Hollingworth; Sean D Sullivan Journal: JAMA Date: 2008-02-13 Impact factor: 56.272
Authors: Steven D Glassman; Christopher L Hamill; Keith H Bridwell; Frank J Schwab; John R Dimar; Thomas G Lowe Journal: Spine (Phila Pa 1976) Date: 2007-11-15 Impact factor: 3.468
Authors: Anthony Rinella; Keith Bridwell; Yongjung Kim; Jonas Rudzki; Charles Edwards; Michael Roh; Lawrence Lenke; Annette Berra Journal: Spine (Phila Pa 1976) Date: 2004-02-01 Impact factor: 3.468
Authors: Sayf S A Faraj; Miranda L van Hooff; Roderick M Holewijn; David W Polly; Tsjitske M Haanstra; Marinus de Kleuver Journal: Eur Spine J Date: 2017-05-22 Impact factor: 3.134
Authors: Peter A Christiansen; Michael LaBagnara; Durga R Sure; Christopher I Shaffrey; Justin S Smith Journal: Curr Rev Musculoskelet Med Date: 2016-09
Authors: Steven D Glassman; Leah Y Carreon; Christopher I Shaffrey; Michael P Kelly; Charles H Crawford; Elizabeth L Yanik; Jon D Lurie; R Shay Bess; Christine R Baldus; Keith H Bridwell Journal: Spine Deform Date: 2020-07-06
Authors: Peter G Passias; Frank A Segreto; Kevin A Moattari; Renaud Lafage; Justin S Smith; Breton G Line; Robert K Eastlack; Douglas C Burton; Robert A Hart; Shay Bess; Christopher I Shaffrey; Christopher P Ames; Virginie Lafage Journal: Spine Deform Date: 2022-03-09
Authors: Ferran Pellisé; Alba Vila-Casademunt; Montse Ferrer; Montse Domingo-Sàbat; Juan Bagó; Francisco J S Pérez-Grueso; Ahmet Alanay; A F Mannion; Emre Acaroglu Journal: Eur Spine J Date: 2014-09-14 Impact factor: 3.134
Authors: Zorica Buser; Brandon Ortega; Anthony D'Oro; William Pannell; Jeremiah R Cohen; Justin Wang; Ray Golish; Michael Reed; Jeffrey C Wang Journal: Global Spine J Date: 2017-04-07